Gaize, Inc., on the 17th of November, 2022, announced the completion of the world’s most extensive clinical research investigating cannabis impairment. Gaize’s portable, non-invasive testing apparatus was employed in the 350-person study to assess pupillary reflex and eye movement response alterations.
The heavyweight is a network meta-analysis of 28 randomized controlled trials covering 3,058 adults, which…
So, will Texas legalize? Maybe not in 2027. But the people who blocked it are…
Struggling cannabis farms are eyeing a second life as data centers. The grow room you…
Low-dose THC beverages typically contain somewhere between 2 and 5 mg of THC per serving.…
A few dozen strangers answered one question, and here's what they told me. Cannabis rarely…
Federal officials admitted under oath at the DEA marijuana rescheduling hearing that the 54-year-old test…